There were 1,107 press releases posted in the last 24 hours and 400,706 in the last 365 days.

Study: EBV Infection is Linked to Chronic Fatigue; The CBCD Recommends Novirin to Reduce Chronic Fatigue

Up to 12% of all EBV infections may result in long-term, lasting feelings of fatigue. (1)

In addition to the fatigue that may result from infection with the virus, antiviral medications may cause even more feelings of fatigue.
— Greg Bennett, CBCD
ROCHESTER, NEW YORK, UNITED STATES, February 10, 2015 /EINPresswire.com/ --

“Infected with the Epstein Barr Virus (EBV)? The CBCD, which conducted two separate post-marketing clinical studies on the natural, antiviral formula of Novirin, recommends taking this effective remedy to help the immune system target the latent EBV virus.” - Greg Bennett, CBCD

A new report shows a link between EBV and long-term Chronic Fatigue. (1) Dr. Muireann De Paor and colleagues wrote that “fatigue after acute IM (infectious mononucleosis, which is caused by EBV) can be severe and persistent. Persistent fatigue was present in 12% of cases at six months after illness onset.” (1) Dr. Paor is from the RCSI Medical School in Dublin, Ireland. In addition to the fatigue that may result from infection with the virus, antiviral medications may cause even more feelings of fatigue. “The most commonly reported side effects of acyclovir (observed in between 1/10 and 1/100 of cases) are nausea, vomiting, diarrhoea and abdominal pain, headache, dizziness, (and) fatigue….” (1) Finally, the CBCD reminds the public that EBV infection, which results in infectious mononucleosis “can lead to significant loss of time from school or work due to profound fatigue, or the development of chronic illness.” (1) To help prevent feelings of fatigue, the CBCD recommends that EBV infected individuals take Novirin. The formula of this natural EBV remedy was shown to effectively reduce viral symptoms in two separate post-marketing clinical studies that followed FDA guidelines.

Click to learn more about EBV symptoms.

The formula of Novirin was tested by Hanan Polansky and Edan Itzkovitz from the CBCD in two clinical studies that followed FDA guidelines. The studies showed that the Novirin formula is effective against the herpes simplex family of viruses, which includes EBV. The clinical studies were published in the peer reviewed, medical journal Pharmacology & Pharmacy, the first, in a special edition on Advances in Antiviral Drugs. Study authors wrote that, “individuals infected with the (EBV) … reported a safe decrease in their symptoms following treatment with Gene-Eden-VIR.” (2) The study authors also wrote that, “we observed a statistically significant decrease in the severity, duration, and frequency of symptoms.” (2)

Novirin can be ordered online through the product website, here: http://www.novirin.com

Novirin is a natural antiviral dietary supplement. Its formula contains five natural ingredients: Selenium, Camellia Sinesis Extract, Quercetin, Cinnamomum Extract, and Licorice Extract. The first ingredient is a trace element, and the other four are plant extracts. Each ingredient and its dose was chosen through a scientific approach. Scientists at polyDNA, the company that invented and patented the formula, scanned thousands of scientific and medical papers published in various medical and scientific journals, and identified the safest and most effective natural ingredients against latent viruses. To date, Novirin is the only natural antiviral product on the market with published clinical studies that support its claims.

How is EBV linked to Chronic Fatigue?

“One theory, developed by Dr. Lerner and a group at The Ohio State University (that includes Drs. Ariza, Glaser, and Williams), proposes that EBV undergoes ‘abortive replication’ in some people… in abortive replication, a defective form of EBV produces early proteins, but is unable to produce later ones. The Ohio State group believes continual production of these proteins is causing a chronic inflammatory state in some people with ME/CFS.” (See Simmaron Research, from March 10, 2014) (3)

Another theory that shares some ideas with abortive replication was presented by Dr. Hanan Polansky, in 2003. (See CBCD.net) (4). According to Dr. Polansky, during the EBV latency phase, the virus still produces proteins. The viral DNA which includes sequences called N-boxes that cause most major diseases. The viral N-boxes microcompete with the human DNA and can causes the human DNA to produce abnormal levels of human proteins. This leads to disease.

In both theories, the human disease is caused by the production of a limited set of viral proteins, a set which is different from that of a fully functioning active virus. In other words, both theories do need the virus to be active for a disease process to start. They only need the presence of the virus, and the production of a limited set of proteins. Dr. Polansky’s theory uses the common term, “latency”, while Dr. Lerner’s theory uses the term “abortive replication.”

To learn more about Dr. Hanan Polansky’s research and the Theory of Microcompetition with Foreign DNA, visit: http://www.cbcd.net (4).

“We recommend that if you suffer from chronic fatigue, you should get an EBV blood test. If positive, talk to your doctor about Novirin.” - Greg Bennett, CBCD

Interested individuals can view the published study on the formula of Novirin and fatigue here: (See Pharmacology & Pharmacy, from March, 2014) (5).

http://www.scirp.org/journal/PaperInformation.aspx?PaperID=44234#.VNiOxeaUf90

To learn more about Novirin, visit http://www.novirin.com
All orders of Novirin are completely confidential, and no information is shared or sold to any third party. Privacy is assured.

References:

(1) Muireann De Paor*, Kirsty O'Brien, Tom Fahey, Susan M Smith "Antiviral agents for infectious mononucleosis (glandular fever)." Cochrane Library - Published Online January 22, 2015.
http://onlinelibrary.wiley.com/doi/10.1002/14651858.CD011487/full

(2) Polansky, H. Itzkovitz, E. Gene-Eden-VIR Is Antiviral: Results of a Post Marketing Clinical Study. Published in September 2013.
http://www.scirp.org/journal/PaperInformation.aspx?PaperID=36101#.U-s9ouOSz90

(3) EBV I: A Deficient Immune Response, Increased Levels of Epstein-Barr Virus Opens Up EBV Question in Chronic Fatigue Syndrome Again. Published on March 10, 2014.
http://simmaronresearch.com/2014/03/1591/

(4) The Center for the Biology of Chronic Disease (CBCD)
http://www.cbcd.net/index.php

(5) Eden-VIR Decreased Physical and Mental Fatigue in a Post Marketing Clinical Study That Followed FDA Guidelines; Results Support Microcompetition Theory. Published in March 2014. http://www.cbcd.net/Gene-Eden-VIR-Decreases-Fatigue-Clinical-Study.php


Hanan Polansky
Lilac Corp.
5852509999
email us here